| NCT06700070 |
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors |
| NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
| NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
| NCT05564377 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial |
| NCT07318805 |
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors |
| NCT05867251 |
Study of AVZO-021 in Patients With Advanced Solid Tumors |
| NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT06559540 |
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer |
| NCT06049355 |
EMBRACE: Exercising Together |
| NCT06253871 |
A Phase 1/1b Study of IAM1363 in HER2 Cancers |
| NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
| NCT04529044 |
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer |
| NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy |
| NCT06952803 |
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
| NCT07447700 |
A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer |
| NCT06165419 |
Definitive Radiation for High-Risk Spine Metastases |
| NCT05996107 |
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer |
| NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/Low IBC |
| NCT03448926 |
The PREDICT Registry: |
| NCT05098210 |
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma |
| NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
| NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
| NCT07220135 |
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer |
| NCT05020574 |
Microbiome and Association With Implant Infections |
| NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies |
| NCT01000883 |
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior |
| NCT05972343 |
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients |
| NCT06500455 |
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
| NCT03488693 |
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer |
| NCT05673200 |
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer |
| NCT07574671 |
Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer |
| NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
| NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
| NCT04923542 |
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases |
| NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
| NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
| NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
| NCT06349642 |
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform |
| NCT03424005 |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer |
| NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
| NCT07127003 |
ILR to Prevent BRCL_MCC 23608 |
| NCT07231159 |
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots |
| NCT07115043 |
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors |
| NCT06926868 |
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) |
| NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
| NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
| NCT06318897 |
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer |
| NCT06295744 |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT06864754 |
WashU DIEP Flap Video and Patient Understanding Improvement |
| NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
| NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
| NCT04169542 |
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery |
| NCT04852887 |
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) |
| NCT06500481 |
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial |
| NCT06744465 |
NearWave Optical Molecular Monitoring |
| NCT07016399 |
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC |
| NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
| NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
| NCT06902311 |
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) |
| NCT05890677 |
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema |
| NCT07076485 |
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer |
| NCT07242118 |
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management |
| NCT04985032 |
Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) |
| NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
| NCT07071038 |
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients |
| NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
| NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
| NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
| NCT06113016 |
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors |
| NCT07285044 |
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas |
| NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer |
| NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
| NCT04766190 |
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT04150042 |
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells |
| NCT06896474 |
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers |
| NCT04119024 |
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
| NCT05219695 |
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
| NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
| NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| NCT04603209 |
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer |
| NCT07095114 |
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. |
| NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
| NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
| NCT06512350 |
Identifying Patterns in the Breath of Individuals With Breast Cancer |
| NCT07264790 |
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon |
| NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
| NCT07014618 |
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer |
| NCT06184750 |
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
| NCT06324240 |
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer |
| NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
| NCT07211178 |
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies |
| NCT07327489 |
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies |
| NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
| NCT06961955 |
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer |
| NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
| NCT07214610 |
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study |
| NCT07166042 |
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies |
| NCT01042379 |
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer |
| NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
| NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
| NCT06006806 |
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy |
| NCT04703244 |
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer |
| NCT05585788 |
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients |
| NCT07140172 |
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery |
| NCT05379153 |
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial |
| NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
| NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
| NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
| NCT07276880 |
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer |
| NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
| NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
| NCT01766297 |
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer |
| NCT04144023 |
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ |
| NCT07137468 |
Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk |
| NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
| NCT06574022 |
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks |
| NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
| NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT02743858 |
Lymphedema Surveillance Study |
| NCT07555210 |
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy |
| NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
| NCT05592938 |
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) |
| NCT07053085 |
A Study of Surgery and Radiotherapy in People With Breast Cancer |
| NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
| NCT07262138 |
Active Surveillance in Older Women With ER+ Breast Cancer |
| NCT06507618 |
Pre-Operative Window of ET to Inform RT Decisions (POWER II) |
| NCT06058377 |
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer |
| NCT06524895 |
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery |
| NCT04888975 |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery |
| NCT06185205 |
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy |
| NCT03463954 |
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors |
| NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
| NCT06953882 |
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy |
| NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
| NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
| NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT06860815 |
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer |
| NCT06856499 |
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer |
| NCT04389281 |
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma |
| NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
| NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
| NCT07294703 |
Factors Associated With Breast Cancer Risks and Outcomes |
| NCT07218432 |
A Study of the TheraBionic P1 Device in Breast Cancer |
| NCT07206121 |
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery |
| NCT04567420 |
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) |
| NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
| NCT07209436 |
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction |
| NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
| NCT00898131 |
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer |
| NCT05989828 |
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer |
| NCT06995898 |
The Vanguard Study: Testing a New Way to Screen for Cancer |
| NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
| NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
| NCT05064098 |
Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients |
| NCT06999798 |
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial |
| NCT07085767 |
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer |
| NCT02701244 |
A Registry Study of Breast Microseed Treatment |
| NCT06179303 |
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer |
| NCT03536897 |
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry |
| NCT05704283 |
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer |
| NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
| NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
| NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
| NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
| NCT05507879 |
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer |
| NCT07340541 |
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies |
| NCT03643861 |
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) |
| NCT07546331 |
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction |
| NCT04563507 |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
| NCT06966700 |
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) |
| NCT06129747 |
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast |
| NCT06867484 |
Breast Re-irradiation After Second Ipsilateral Lumpectomy |
| NCT05491226 |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation |
| NCT06763328 |
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy |
| NCT05595577 |
Improving Exercise Capacity With a Tailored Physical Activity Intervention |
| NCT07112053 |
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
| NCT07224464 |
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. |
| NCT06888388 |
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer |
| NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
| NCT04368702 |
CONFIRM: Magnetic Resonance Guided Radiation Therapy |
| NCT07402473 |
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer |
| NCT00005095 |
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention |
| NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
| NCT06960707 |
Two Versus One Week Breast Radiotherapy (RT) |
| NCT00823654 |
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations |
| NCT05837455 |
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer |
| NCT06502691 |
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer |
| NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
| NCT04517838 |
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer |
| NCT05030038 |
Oral Aromatase Inhibitors Modify the Gut Microbiome |
| NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
| NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
| NCT05786664 |
Breast Cancer Survivorship Biorepository |
| NCT01185132 |
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy |
| NCT07087691 |
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT01503190 |
The Immune System's Response to Young Women's Breast Cancer |
| NCT06876714 |
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab |
| NCT06910761 |
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer |
| NCT06896162 |
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT06671730 |
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer |
| NCT04049214 |
Perioperative Mindfulness Proposal |
| NCT04373564 |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years |
| NCT07558733 |
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer |
| NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
| NCT05633654 |
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) |
| NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
| NCT04650256 |
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences |
| NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
| NCT07122713 |
Definitive Radiation Therapy for Inoperable Breast Cancer |
| NCT00353483 |
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells |
| NCT06998407 |
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors |
| NCT05315700 |
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration |
| NCT06897488 |
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT07137416 |
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer |
| NCT07078604 |
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer |
| NCT04715958 |
SHAPE Neoadjuvant Chemotherapy Response |
| NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT05288777 |
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer |
| NCT03694756 |
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer |
| NCT04038619 |
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients |
| NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
| NCT06758102 |
Dance Study for Post-surgical Pain in Breast Cancer Survivors |
| NCT05768139 |
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
| NCT05812807 |
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab |
| NCT02772367 |
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT07597837 |
Oncoplastic Surgery Outcomes Database |
| NCT04550494 |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations |
| NCT06445738 |
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) |
| NCT07391774 |
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial |
| NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer |
| NCT06582615 |
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer |
| NCT06938581 |
ERAS Protocols in Breast Conserving Surgery |
| NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT03936478 |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
| NCT05534438 |
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT05406232 |
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer |
| NCT07216105 |
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors |
| NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
| NCT06841354 |
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
| NCT06055881 |
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy |
| NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
| NCT05528133 |
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer |
| NCT00899301 |
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer |
| NCT07483307 |
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT07044310 |
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss |
| NCT02250352 |
Core Biopsies for Establishing a Breast Tumor Tissue Repository |
| NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
| NCT06492759 |
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer |
| NCT07308717 |
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol |
| NCT06525766 |
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer |
| NCT04494945 |
Identifying and Caring for Individuals With Inherited Cancer Syndrome |
| NCT05561842 |
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries) |
| NCT02945579 |
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy |
| NCT06966388 |
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT04636710 |
Refining Local-Regional Therapy for IBC |
| NCT07044583 |
SAVE Trial: SAfe Opioid Use Video Education |
| NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
| NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
| NCT06813053 |
A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer |
| NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients |
| NCT06347068 |
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells |
| NCT05941520 |
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer |
| NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
| NCT06817226 |
BREAST Choice Decision Tool R21 - AIM2 |
| NCT06195306 |
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
| NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial |
| NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
| NCT07017673 |
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer |
| NCT06903468 |
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions |
| NCT07335354 |
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery |
| NCT06954831 |
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer |
| NCT05872295 |
IKS014 in Advanced Solid Tumors That Express HER2 |
| NCT04075305 |
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study |
| NCT06294574 |
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
| NCT06435351 |
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy |
| NCT04553770 |
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer |
| NCT06981208 |
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction |
| NCT05774678 |
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation |
| NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
| NCT07066189 |
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC |
| NCT07118176 |
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT07220967 |
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement |
| NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
| NCT06681233 |
Feasibility Study of CBCT for IGRT in Cancer Patients |
| NCT06220214 |
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer |
| NCT03808337 |
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease |
| NCT05417867 |
Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
| NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
| NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
| NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer |
| NCT06471673 |
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer |
| NCT06238921 |
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases |
| NCT07478016 |
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients |
| NCT07020117 |
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors |
| NCT06731894 |
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT06252662 |
Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies |
| NCT04485013 |
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers |
| NCT04994067 |
Intra-Operative Radiation Registry |
| NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
| NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
| NCT06247995 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
| NCT06953245 |
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy |
| NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
